Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Galmed Pharmaceutica (GLMD)

Galmed Pharmaceutica (GLMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Galmed Pharmaceutica 16 ABBA HILLEL ROAD RAMAT GAN L3 5250608 ISR

www.galmedpharma.com Employees: 8 P: 972-3693-8448 F: 972-369-3844

Description:

Galmed Pharmaceuticals Ltd. is a clinical-stage biopharmaceutical company. It is focused on developing therapies for liver diseases and gallstones. Galmed Pharmaceuticals Ltd. is based in Tel Aviv, Israel.

Key Statistics

Overview:

Market Capitalization, $K 1,905
Enterprise Value, $K -1,075
Shares Outstanding, K 644
Annual Sales, $ 0 K
Annual Net Income, $ -6,910 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -1,910 K
EBIT, $ -6,780 K
EBITDA, $ -6,730 K
60-Month Beta 0.80
% of Insider Shareholders 19.80%
% of Institutional Shareholders 76.14%
Float, K 516
% Float 80.20%
Short Volume Ratio 0.29

Growth:

1-Year Return -35.20%
3-Year Return -99.41%
5-Year Return -99.65%
5-Year Revenue Growth -100.00%
5-Year Earnings Growth 69.12%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -2.31 on 11/14/24
Next Earnings Date 11/27/24 [--]
Earnings Per Share ttm -16.66
EPS Growth vs. Prev Qtr -1,383.33%
EPS Growth vs. Prev Year 19.83%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-12 on 08/30/24

GLMD Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -28.75%
Return-on-Assets % -24.98%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.10
Book Value/Share 28.81
Interest Coverage -0.76
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar